Sfoglia per Autore
Immune-Reconstituent Influenza Virosome (IRIV)containing CD40L gene,a powerful immunological enhancer with antigen specific anti-cancer vaccines
2005-01-01 P., Correale; Cusi, MARIA GRAZIA; G., Giorgi; Francini, Guido
Virosoma dell'influenza immunoricostituito (IRIV) contenente il gene per CD40L come immunoprotettore tumorale CEA-specifico e usi immunogenici di esso.
2005-01-01 Cusi, MARIA GRAZIA; Giorgi, G; Francini, Guido; Correale, P.
THYMIDYLATE SYNTHASE RELATED POLYEPITOPE PEPTIDE CANCER THERAPEUTICS
2005-01-01 P., Correale; Cusi, MARIA GRAZIA; G., Giorgi; Francini, Guido
Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials.
2005-01-01 Sargent, Dj; Wieand, Hs; Haller, Dg; Gray, R; Benedetti, Jk; Buyse, M; Labianca, R; Seitz, Jf; O'Callaghan, Cj; Francini, Guido; Grothey, A; O'Connell, M; Catalano, Pj; Blanke, Cd; Kerr, D; Green, E; Wolmark, N; Andre, T; Goldberg, Rm; DE GRAMONT, A.
Immune-reconstituted influenza virosome containing CD40L gene enhances the immunological and protective activity of a carcinoembryonic antigen anticancer vaccine
2005-01-01 Cusi, MARIA GRAZIA; DEL VECCHIO, MARIA TERESA; Terrosi, C.; GORI SAVELLINI, G.; DI GENOVA, G.; LA PLACA, M.; Fallarono, F.; Moser, C.; Cardone, A.; Giorni, G.; Francini, Guido; Correale, P.
Dendritic cell-cediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro
2005-01-01 Correale, P.; Cusi, MARIA GRAZIA; DEL VECCHIO, MARIA TERESA; Aquino, A.; Prete, S.; Tsang, K. Y.; Micheli, Lucia; Nencini, Cristina; Giorgi, Giorgio; LA PLACA, M.; Montagnani, F.; Terrosi, Chiara; Caraglia, M.; Formica, V.; Bonmassar, E.; Francini, Guido
Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumor activity in metastatic colon cancer patients.
2005-01-01 Correale, P.; Cusi, M. G.; Tsang, K. Y.; DEL VECCHIO, MARIA TERESA; Marsili, S.; LA PLACA, M.; Intrivici, C.; Aquino, A.; Micheli, Lucia; Nencini, Cristina; Ferrari, Francesco; Giorgi, Giorgio; Bonmassar, E.; Francini, Guido
Immunotherapy of renal cell carcinoma with granulocyte macrophage colony stimulating factor and very low dose interleukin-2
2005-01-01 Correale, P.; Marsili, S.; Sabatino, M.; Montagnani, F.; Giorgi, G.; Francini, G.
Folinic acid, 5-fluorouracil and etoposide after curative resection for gastric cancer.
2005-01-01 Petrioli, R; Sabatino, M; Roviello, Franco; Marrelli, Daniele; Nastri, G; Marsili, S; Correale, P; Pozzessere, D; Messinese, S; DE MARTINO, A; Tani, Francesco; Marzocca, Giuseppe; Lorenzi, Marco; Civitelli, Serenella; Tanzini, Gabriello; Pinto, Enrico; Francini, Guido
Immunological and anti-tumor activity of a novel a chemo-immunotherapy regimen with gemcitabine, oxaliplatin, levo-folinic acid, and 5-fluorouracil followed by GM-CSF and Interleukin-2 in patients with metastatic colorectal cancer
2005-01-01 Correale, P.; Cusi, M. G.; Tsang, K. Y.; Del Vecchio, M. T.; Marsili, S.; Intrivici, C.; La Placa, M.; Aquino, A.; Bonmassar, E.; Francini, G.
Gemcitabine (GEM) plus oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX-4) in patients with advanced gastric cancer
2005-01-01 Correale, Pierpaolo; Fulfaro, Fabio; Marsili, Stefania; Cicero, Giuseppe; Bajardi, Eugenia; Intrivici, Chiara; Vuolo, Giuseppe; Carli, Antonio Ferdinando; Caraglia, Michele; Prete, Salvatore Del; Greco, Ettore; Gebbia, Nicola; Francini, Guido
Chemotherapy regimen GOLF induces apoptosis in colon cancer cells through multi-chaperone complex inactivation and increased Raf-1 ubiquitin-dependent degradation
2005-01-01 Caraglia, M.; Marra, M.; Budillon, A.; Meo, G.; Ricciardiello, F.; Bismuto, E.; Brachelente, G.; Francini, G.; Giordano, A.; Correale, P.; Abbruzzese, A.
5-fluorouracil-based chemotherapy enhances the antitumor activity of a thymidylate synthase-directed polyepitopic peptide vaccine
2005-01-01 Correale, P.; DEL VECCHIO, M. T.; DI GENOVA, G.; LA PLACA, M.; Terrosi, C.; GORI SAVELLINI, G.; Vestri, M.; Urso, R.; Lemonnier, F.; Aquino, A.; Bonmassar, E.; Giorgi, G.; Francini, Guido; Cusi, MARIA GRAZIA
Chemo-immunotherapy of colo-rectal cancer: Drug induced antigen specific cell-mediated immune response in vitro and in cancer patients
2004-01-01 Pierpaolo, Correale; Angelo, Aquino; Cusi, MARIA GRAZIA; Maria Teresa Del, Vecchio; Micheli, Lucia; Cristina, Nencini; Marco La, Placa; Marco La, Placa; Francesco, Montagnani; Anna, Giuliani; Mario, Turriziani; Giorgio, Giorgi; Enzo, Bonmassar; Francini, Guido
Disease-free survival (DFS) vs. overall survival (OS) as a primary endpoint for adjuvant colon cancer studies: Individual patient data from 12,915 patients on 15 randomized trials
2004-01-01 D. J., Sargent; S., Wieand; J., Benedetti; R., Labianca; D. G., Haller; L. E., Shepherd; J. F., Seitz; Francini, Guido; A., De Gramont; R. M., Goldberg
Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
2004-01-01 Gill, S.; Loprinzi, C. L.; Sargent, D. J.; Thome, S. D.; Alberts, S. R.; Haller, D. G.; Benedetti, J.; Francini, G.; Shepherd, L. E.; FRANCOIS SEITZ, J.; Labianca, R.; Chen, W.; Cha, S. S.; Heldebrant, M. P.; Goldberg, R. M.
A novel biweekly multidrug regimen of gemcitabine, oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) in pretreated patients with advanced colorectal carcinoma
2004-01-01 Correale, P; Messinese, S; Caraglia, M; Marsili, S; Piccolomini, Alessandro; Petrioli, R; Ceciarini, F; Micheli, Lucia; Nencini, C; Neri, Alessandro; Vuolo, G; Guarnieri, Alfredo; Abbruzzese, A; Prete, Sd; Giorgi, Giorgio; Francini, Guido
UFT/leucovorin and oxaliplatin alternated with UFT/leucovorin and irinotecan in metastatic colorectal cancer
2004-01-01 Petrioli, R.; Sabatino, M.; Fiaschi, A. I.; Marsili, S.; Pozzessere, D.; Messinese, S.; Correale, P.; Civitelli, Serenella; Tanzini, Gabriello; Tani, Francesco; DE MARTINO, A.; Marzocca, Giuseppe; Lorenzi, Marco; Giorgi, Giorgio; Francini, Guido
Analysis of biochemical bone markers as prognostic factors for survival in patients with hormone-resistant prostate cancer and bone metastases
2004-01-01 Petrioli, R.; Rossi, S.; Caniggia, M.; Pozzessere, D.; Messinese, S.; Sabatino, M.; Marsili, S.; Correale, P.; Salvestrini, F.; Manganelli, A.; Francini, G.
Gemcitabine (GEM), 5-fluorouracil (5-FU) and folinic acid (FA) in patients with different gastroenteric malignancies
2004-01-01 Correale, P.; Cerretani, Daniela; Clerici, M.; Messinese, S; Marsili, S.; Petrioli, R.; Cetta, Francesco; Savelli, Vinno; Guarnieri, Alfredo; Pinto, Enrico; Giorgi, Giorgio; Francini, Guido
| Titolo | Data di pubblicazione | Autore(i) | File | Abstract |
|---|---|---|---|---|
| Immune-Reconstituent Influenza Virosome (IRIV)containing CD40L gene,a powerful immunological enhancer with antigen specific anti-cancer vaccines | 1-gen-2005 | P., Correale; Cusi, MARIA GRAZIA; G., Giorgi; Francini, Guido | - | |
| Virosoma dell'influenza immunoricostituito (IRIV) contenente il gene per CD40L come immunoprotettore tumorale CEA-specifico e usi immunogenici di esso. | 1-gen-2005 | Cusi, MARIA GRAZIA; Giorgi, G; Francini, Guido; Correale, P. | - | |
| THYMIDYLATE SYNTHASE RELATED POLYEPITOPE PEPTIDE CANCER THERAPEUTICS | 1-gen-2005 | P., Correale; Cusi, MARIA GRAZIA; G., Giorgi; Francini, Guido | - | |
| Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials. | 1-gen-2005 | Sargent, Dj; Wieand, Hs; Haller, Dg; Gray, R; Benedetti, Jk; Buyse, M; Labianca, R; Seitz, Jf; O'Callaghan, Cj; Francini, Guido; Grothey, A; O'Connell, M; Catalano, Pj; Blanke, Cd; Kerr, D; Green, E; Wolmark, N; Andre, T; Goldberg, Rm; DE GRAMONT, A. | - | |
| Immune-reconstituted influenza virosome containing CD40L gene enhances the immunological and protective activity of a carcinoembryonic antigen anticancer vaccine | 1-gen-2005 | Cusi, MARIA GRAZIA; DEL VECCHIO, MARIA TERESA; Terrosi, C.; GORI SAVELLINI, G.; DI GENOVA, G.; LA PLACA, M.; Fallarono, F.; Moser, C.; Cardone, A.; Giorni, G.; Francini, Guido; Correale, P. | - | |
| Dendritic cell-cediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro | 1-gen-2005 | Correale, P.; Cusi, MARIA GRAZIA; DEL VECCHIO, MARIA TERESA; Aquino, A.; Prete, S.; Tsang, K. Y.; Micheli, Lucia; Nencini, Cristina; Giorgi, Giorgio; LA PLACA, M.; Montagnani, F.; Terrosi, Chiara; Caraglia, M.; Formica, V.; Bonmassar, E.; Francini, Guido | - | |
| Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumor activity in metastatic colon cancer patients. | 1-gen-2005 | Correale, P.; Cusi, M. G.; Tsang, K. Y.; DEL VECCHIO, MARIA TERESA; Marsili, S.; LA PLACA, M.; Intrivici, C.; Aquino, A.; Micheli, Lucia; Nencini, Cristina; Ferrari, Francesco; Giorgi, Giorgio; Bonmassar, E.; Francini, Guido | - | |
| Immunotherapy of renal cell carcinoma with granulocyte macrophage colony stimulating factor and very low dose interleukin-2 | 1-gen-2005 | Correale, P.; Marsili, S.; Sabatino, M.; Montagnani, F.; Giorgi, G.; Francini, G. | - | |
| Folinic acid, 5-fluorouracil and etoposide after curative resection for gastric cancer. | 1-gen-2005 | Petrioli, R; Sabatino, M; Roviello, Franco; Marrelli, Daniele; Nastri, G; Marsili, S; Correale, P; Pozzessere, D; Messinese, S; DE MARTINO, A; Tani, Francesco; Marzocca, Giuseppe; Lorenzi, Marco; Civitelli, Serenella; Tanzini, Gabriello; Pinto, Enrico; Francini, Guido | - | |
| Immunological and anti-tumor activity of a novel a chemo-immunotherapy regimen with gemcitabine, oxaliplatin, levo-folinic acid, and 5-fluorouracil followed by GM-CSF and Interleukin-2 in patients with metastatic colorectal cancer | 1-gen-2005 | Correale, P.; Cusi, M. G.; Tsang, K. Y.; Del Vecchio, M. T.; Marsili, S.; Intrivici, C.; La Placa, M.; Aquino, A.; Bonmassar, E.; Francini, G. | - | |
| Gemcitabine (GEM) plus oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX-4) in patients with advanced gastric cancer | 1-gen-2005 | Correale, Pierpaolo; Fulfaro, Fabio; Marsili, Stefania; Cicero, Giuseppe; Bajardi, Eugenia; Intrivici, Chiara; Vuolo, Giuseppe; Carli, Antonio Ferdinando; Caraglia, Michele; Prete, Salvatore Del; Greco, Ettore; Gebbia, Nicola; Francini, Guido | - | |
| Chemotherapy regimen GOLF induces apoptosis in colon cancer cells through multi-chaperone complex inactivation and increased Raf-1 ubiquitin-dependent degradation | 1-gen-2005 | Caraglia, M.; Marra, M.; Budillon, A.; Meo, G.; Ricciardiello, F.; Bismuto, E.; Brachelente, G.; Francini, G.; Giordano, A.; Correale, P.; Abbruzzese, A. | - | |
| 5-fluorouracil-based chemotherapy enhances the antitumor activity of a thymidylate synthase-directed polyepitopic peptide vaccine | 1-gen-2005 | Correale, P.; DEL VECCHIO, M. T.; DI GENOVA, G.; LA PLACA, M.; Terrosi, C.; GORI SAVELLINI, G.; Vestri, M.; Urso, R.; Lemonnier, F.; Aquino, A.; Bonmassar, E.; Giorgi, G.; Francini, Guido; Cusi, MARIA GRAZIA | - | |
| Chemo-immunotherapy of colo-rectal cancer: Drug induced antigen specific cell-mediated immune response in vitro and in cancer patients | 1-gen-2004 | Pierpaolo, Correale; Angelo, Aquino; Cusi, MARIA GRAZIA; Maria Teresa Del, Vecchio; Micheli, Lucia; Cristina, Nencini; Marco La, Placa; Marco La, Placa; Francesco, Montagnani; Anna, Giuliani; Mario, Turriziani; Giorgio, Giorgi; Enzo, Bonmassar; Francini, Guido | - | |
| Disease-free survival (DFS) vs. overall survival (OS) as a primary endpoint for adjuvant colon cancer studies: Individual patient data from 12,915 patients on 15 randomized trials | 1-gen-2004 | D. J., Sargent; S., Wieand; J., Benedetti; R., Labianca; D. G., Haller; L. E., Shepherd; J. F., Seitz; Francini, Guido; A., De Gramont; R. M., Goldberg | - | |
| Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? | 1-gen-2004 | Gill, S.; Loprinzi, C. L.; Sargent, D. J.; Thome, S. D.; Alberts, S. R.; Haller, D. G.; Benedetti, J.; Francini, G.; Shepherd, L. E.; FRANCOIS SEITZ, J.; Labianca, R.; Chen, W.; Cha, S. S.; Heldebrant, M. P.; Goldberg, R. M. | - | |
| A novel biweekly multidrug regimen of gemcitabine, oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) in pretreated patients with advanced colorectal carcinoma | 1-gen-2004 | Correale, P; Messinese, S; Caraglia, M; Marsili, S; Piccolomini, Alessandro; Petrioli, R; Ceciarini, F; Micheli, Lucia; Nencini, C; Neri, Alessandro; Vuolo, G; Guarnieri, Alfredo; Abbruzzese, A; Prete, Sd; Giorgi, Giorgio; Francini, Guido | - | |
| UFT/leucovorin and oxaliplatin alternated with UFT/leucovorin and irinotecan in metastatic colorectal cancer | 1-gen-2004 | Petrioli, R.; Sabatino, M.; Fiaschi, A. I.; Marsili, S.; Pozzessere, D.; Messinese, S.; Correale, P.; Civitelli, Serenella; Tanzini, Gabriello; Tani, Francesco; DE MARTINO, A.; Marzocca, Giuseppe; Lorenzi, Marco; Giorgi, Giorgio; Francini, Guido | - | |
| Analysis of biochemical bone markers as prognostic factors for survival in patients with hormone-resistant prostate cancer and bone metastases | 1-gen-2004 | Petrioli, R.; Rossi, S.; Caniggia, M.; Pozzessere, D.; Messinese, S.; Sabatino, M.; Marsili, S.; Correale, P.; Salvestrini, F.; Manganelli, A.; Francini, G. | - | |
| Gemcitabine (GEM), 5-fluorouracil (5-FU) and folinic acid (FA) in patients with different gastroenteric malignancies | 1-gen-2004 | Correale, P.; Cerretani, Daniela; Clerici, M.; Messinese, S; Marsili, S.; Petrioli, R.; Cetta, Francesco; Savelli, Vinno; Guarnieri, Alfredo; Pinto, Enrico; Giorgi, Giorgio; Francini, Guido | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile